GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wanbangde Pharmaceutical Holding Group Co 002082.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

9.96

-0.10%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Net income

−CN¥198.8m

FY2016FY2025

Free cash flow

CN¥314.3m

FY2016FY2025

Shareholders' equity

CN¥2.52bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016
Research and developmentCN¥59.2mCN¥59.9mCN¥54.0mCN¥59.1mCN¥76.2mCN¥184.9mCN¥163.4mCN¥50.6mCN¥43.4m
Operating income−CN¥172.9mCN¥60.1mCN¥72.2mCN¥128.7mCN¥375.2mCN¥399.3mCN¥516.6mCN¥116.9mCN¥75.2m
Net income−CN¥198.8mCN¥55.4mCN¥49.2mCN¥93.3mCN¥166.5mCN¥284.9mCN¥294.5mCN¥98.2mCN¥69.7m
Diluted earnings per share-0.170.090.080.150.260.461.990.420.27

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016
Total assetsCN¥4.39bnCN¥4.33bnCN¥4.30bnCN¥4.22bnCN¥4.37bnCN¥5.66bnCN¥3.80bnCN¥2.10bnCN¥1.66bn
Cash and short-term investments—CN¥169.9mCN¥226.6mCN¥467.6mCN¥912.0mCN¥574.2mCN¥650.9mCN¥280.7mCN¥557.3m
Total liabilitiesCN¥1.78bnCN¥1.57bnCN¥1.54bnCN¥1.40bnCN¥1.63bnCN¥2.80bnCN¥1.89bnCN¥496.6mCN¥261.8m
DebtCN¥172.7mCN¥969.6mCN¥917.8mCN¥863.0mCN¥840.6mCN¥1.86bnCN¥1.36bnCN¥89.6mCN¥112.1m
Shareholders' equityCN¥2.52bnCN¥2.67bnCN¥2.66bnCN¥2.69bnCN¥2.60bnCN¥2.62bnCN¥1.64bnCN¥1.42bnCN¥1.38bn
Shares outstanding1,144m614m628m634m640m613m148m232m254m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016
Cash from operationsCN¥604.0mCN¥120.2m−CN¥72.9m−CN¥239.6mCN¥22.1mCN¥151.0m−CN¥248.7m−CN¥17.6mCN¥310.7m
Capital spending−CN¥289.7m−CN¥88.4m−CN¥128.7m−CN¥167.2m−CN¥277.1m−CN¥559.2m−CN¥406.0m−CN¥20.9m−CN¥9.0m
Free cash flowCN¥314.3mCN¥31.8m−CN¥201.6m−CN¥406.9m−CN¥255.0m−CN¥408.2m−CN¥654.7m−CN¥38.5mCN¥301.7m
Dividends paid−CN¥47.7m−CN¥90.8m−CN¥122.0m−CN¥43.9m−CN¥122.9m−CN¥92.7m−CN¥50.2m−CN¥59.5m−CN¥23.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−CN¥28.8mCN¥117.8m−CN¥201.6m−CN¥9.8m−CN¥6.5mCN¥24.2mCN¥37.8mCN¥16.0m
Net income−CN¥39.7mCN¥103.0m−CN¥203.2m−CN¥9.0m−CN¥1.7mCN¥15.2mCN¥9.7mCN¥8.0m
Diluted earnings per share-0.030.09-0.18-0.01-0.000.010.020.01
Cash from operations———−CN¥1.0mCN¥61.0m−CN¥14.0m—CN¥26.0m
Capital spending—−CN¥37.0m—−CN¥145.0m−CN¥153.0m−CN¥25.0m−CN¥54.0m−CN¥97.0m
Free cash flow———−CN¥146.0m−CN¥92.0m−CN¥39.0m—−CN¥71.0m
Total assetsCN¥4.41bnCN¥4.55bnCN¥4.39bnCN¥4.54bnCN¥4.43bnCN¥4.27bnCN¥4.33bnCN¥4.27bn
Cash and short-term investments———CN¥83.1mCN¥195.5mCN¥56.9mCN¥158.7mCN¥95.8m
DebtCN¥153.4mCN¥153.5mCN¥172.7mCN¥779.3mCN¥856.1mCN¥920.8mCN¥958.0mCN¥918.4m
Shareholders' equityCN¥2.58bnCN¥2.61bnCN¥2.52bnCN¥2.67bnCN¥2.68bnCN¥2.68bnCN¥2.67bnCN¥2.66bn

Financial ratios

Data as of 4 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-15.1%4.2%4.7%7.2%19.4%2.9%
Net margin-17.4%3.8%3.2%5.2%8.6%2.1%
Return on equity-7.9%2.1%1.9%3.5%6.4%10.9%
Return on assets-4.5%1.3%1.1%2.2%3.8%5.0%
Free cash flow yield6.0%2.6%0.7%-0.9%3.6%8.9%
Revenue growth-20.7%-6.4%-13.7%-7.5%-85.9%-17.9%
Earnings growth-458.5%12.7%-47.2%-44.0%-41.6%-3.3%
Current ratio1.22x1.37x1.45x1.94x1.92x1.65x
Debt to equity0.07x0.36x0.34x0.30x0.31x0.70x
Equity ratio57.3%61.6%61.9%63.8%59.4%46.3%
Interest coverage-4.54x1.49x1.51x3.79x10.17x6.89x
R&D as a share of sales5.2%4.1%3.5%3.3%3.9%1.3%
Buybacks as a share of market value-86.5%2.3%0.9%1.0%-4.3%-315.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-13.8%-39.1%-20.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-4.4%1.5%4.0%2.5%
Net margin-5.5%-0.0%2.1%1.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-80.271.281.759.956.829.54.733.833.070.8
Price to sales13.92.72.63.14.90.60.17.40.20.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 11 Jul 2024.

FY2024FY2023FY2021FY2020FY2017FY2016FY2015FY2013
Paid in the year0.080.120.200.150.250.100.050.08
  • 8-for-5 split · 10 Jun 2008
  • 8-for-5 split · 28 May 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.